Blockade of Glutamate Release by Botulinum Neurotoxin Type A in Humans: A Dermal Microdialysis Study
BACKGROUND: The analgesic action of botulinum neurotoxin type A (BoNTA) has been linked to the blockade of peripheral release of neuropeptides and neurotransmitters in animal models; however, there is no direct evidence of this in humans.
Saved in:
Main Authors: | Larissa Bittencourt da Silva, Ali Karshenas, Flemming W Bach, Sten Rasmussen, Lars Arendt-Nielsen, Parisa Gazerani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Pain Research and Management |
Online Access: | http://dx.doi.org/10.1155/2014/410415 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive Insight of Neurodegenerative Diseases and The Role of Neurotoxin Agents — Glutamate
by: Hui-Min Yap, et al.
Published: (2020-04-01) -
New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A
by: Marina Vladimirovna Silkina, et al.
Published: (2024-07-01) -
Development of a Cell-Based Functional Assay for the Detection of Clostridium botulinum Neurotoxin Types A and E
by: Uma Basavanna, et al.
Published: (2013-01-01) -
Botulinum Neurotoxin Type A for the Treatment of Benign Prostatic Hyperplasia: Randomized Study Comparing Two Doses
by: René Arnouk, et al.
Published: (2012-01-01) -
Effects of Chronic Musculoskeletal Pain on Fertility Potential in Lean and Overweight Male Patients
by: Fereshteh Dardmeh, et al.
Published: (2017-01-01)